AEON — AEON Biopharma, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-04-12.
Performance
Technicals
Others in Healthcare
Measured signals that fired on AEON
| date | signal | measured base rate |
|---|---|---|
| 2026-06-10 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-19 | LYNCH TIMOTHY P 10% owner | Open-market purchase | 1.1M | 0.21 | 243.5K |
| 2026-06-17 | Carter Eric G Director | Grant or award | 222.7K | 0.00 | 0 |
| 2026-06-17 | Forth Marc Director | Grant or award | 222.7K | 0.00 | 0 |
| 2026-06-17 | PALMISANO ROBERT J Director | Grant or award | 222.7K | 0.00 | 0 |
| 2026-06-17 | Thunen Shelley B Director | Grant or award | 222.7K | 0.00 | 0 |
| 2026-06-17 | FISCHER JOST Director | Grant or award | 222.7K | 0.00 | 0 |
| 2026-04-02 | Bencich John CHIEF FINANCIAL OFFICER | Grant or award | 754.7K | 0.00 | 0 |
| 2026-03-04 | Oh Chad CHIEF MEDICAL OFFICER | Grant or award | 1.3M | 0.00 | 0 |
| 2026-03-04 | Wilson Alexander Blair CLO, CSO, and Corp Secretary | Grant or award | 1.3M | 0.00 | 0 |
| 2026-03-04 | Sy Jennifer PRINCIPAL ACCOUNTING OFFICER | Grant or award | 925.9K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Dauntless Investment Group, LLC | 2.5M | 2.5M |
| VANGUARD CAPITAL MANAGEMENT LLC | 89.2K | 90.5K |
| GEODE CAPITAL MANAGEMENT, LLC | 85.8K | 87.1K |
| Blue Owl Capital Holdings LP | 41.5K | 42.4K |
| Formidable Asset Management, LLC | 22.0K | 20.0K |
| XTX Topco Ltd | 20.1K | 20.4K |
| JANE STREET GROUP, LLC | 16.1K | 16.4K |
| VANGUARD FIDUCIARY TRUST CO | 14.5K | 14.7K |
| LPL Financial LLC | 11.3K | 11.5K |
| UBS Group AG | 4.1K | 4.2K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- AEON Biopharma Q2 Non-GAAP EPS of -$0.02 · 2026-08-13
Ask the AI about AEON
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →